Massive subcutaneous bleeding as a first manifestation of chronic myeloid leukemia in chronic phase.
Nacinovic
Antica Duletic
AD
Department of Internal Medicine, Clinical Hospital Center Rijeka, Kresimirova 52, 51000 Rijeka, Croatia.
Miletic
Bojan
B
Topljak-Polic
Dubravka
D
Balen
Sanja
S
Stimac
Davor
D
D000328:Adult; D000970:Antineoplastic Agents / Q000627:therapeutic use; D004211:Disseminated Intravascular Coagulation; D004438:Ecchymosis / Q000175:diagnosis* / Q000188:drug therapy / Q000209:etiology*; D006801:Humans; D006918:Hydroxyurea / Q000627:therapeutic use; D016898:Interferon-alpha / Q000627:therapeutic use; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000150:complications* / Q000175:diagnosis*; D008297:Male; D012720:Severity of Illness Index
D000970:Antineoplastic Agents; D016898:Interferon-alpha; D006918:Hydroxyurea